Berkeley SkyDeck

Drill Surgeries is a company dedicated to enhancing the outcomes of trauma and orthopedic surgeries through its innovative AI-powered navigation system. This technology aims to significantly reduce the failure rate of surgeries from 36% to less than 4% by providing real-time guidance during osteosynthesis procedures. By employing proprietary AI algorithms and mixed reality technologies, Drill Surgeries facilitates a remarkable 83% reduction in operating room time. Additionally, the company’s solutions eliminate the need for unnecessary X-rays, leading to substantial cost savings of approximately $2,000 per operation for hospitals. Through these advancements, Drill Surgeries empowers doctors to perform complex procedures more efficiently and effectively, ultimately improving patient care and operational efficiency in healthcare settings.

We are an innovative AI-driven digital pathology company, dedicated to shaping the future of diagnostics and research, with a mission to empower accurate diagnoses and elevate patient care globally.

Okomera is a biotech start-up focused on enhancing access to more effective, precision-based cancer therapies. The company has pioneered the automation and miniaturization of individualized tumor biopsy research, developing advanced medical technologies that leverage microfluidic 3D cellular assays. These innovative technologies enable the prediction of patient-specific responses to cancer treatments by automating relevant biopsy testing. In this process, tumor cells are cultivated within thousands of microfluidic droplets and exposed to numerous conditions simultaneously. This approach allows healthcare providers to expedite the development and delivery of modern cancer therapies, ultimately improving treatment outcomes for patients.

MZR Neurotech is a medical technology company focused on sleep monitoring solutions. The company has developed an innovative in-ear electroencephalogram (EEG) sensor that utilizes biosensors to accurately measure brain activity during sleep. This device allows users to enhance their sleep quality by providing valuable insights into their sleep patterns. By leveraging cutting-edge technology, MZR Neurotech aims to contribute to better sleep health and understanding.

Gisens Biotech is a biotechnology company specializing in bioelectronics and nanotechnology. The firm is recognized for its innovative approach to problem-solving and leverages advanced technology to meet its goals. A standout product is the Nano-Lab, a portable diagnostic device that measures and monitors various biomarkers from minimal samples of blood, urine, or saliva. This device is particularly adept at detecting renal biomarkers such as urea, creatinine, and potassium from a single drop of blood. By providing real-time tracking of these concentrations, the Nano-Lab enhances health monitoring capabilities, offering a high level of accuracy and convenience that has the potential to transform traditional biomarker measurement and interpretation methods.

Music Health is dedicated to enhancing the well-being of individuals through the transformative power of music. The company focuses on making music therapy accessible and affordable for everyone, particularly targeting those affected by mental health challenges. Its flagship product, Vera, is designed to support the approximately 60 million individuals living with dementia and their nearly 200 million caregivers by addressing behavioral and psychological symptoms associated with the condition. Additionally, Music Health has developed a patented music application that generates mood-based playlists, allowing users to craft personalized musical experiences that adapt to their emotional states, whether for social gatherings, commuting, or creating an ambiance in various settings. Through these innovative solutions, Music Health aims to empower users to effectively manage their mental health.

GenomeUp is a Rome-based healthtech startup that specializes in AI-powered solutions for genetic analysis and clinical decision support. The company aims to serve as a global reference platform to enhance clinical decision-making for hospitals, laboratories, research centers, and pharmaceutical companies. By providing tools that accelerate diagnosis times and improve patient care, GenomeUp seeks to deliver actionable insights for health prevention within a 24-hour timeframe. Emphasizing its commitment to social responsibility, the company has evolved into an Italian Benefit Corporation, prioritizing sustainable and transparent practices that consider the well-being of stakeholders, communities, and the environment.

CenSyn is a healthcare company focused on advancing brain health screening through innovative technology. The company develops a handheld EEG monitoring device that facilitates the expedited screening of conditions such as Alzheimer's, traumatic brain injury, and epilepsy. Their proprietary software allows for long-term brain health management, capturing brain electrical activity in real-time and enabling clinicians to access EEG data wirelessly from any location. This technological approach not only aids in the rapid diagnosis of various brain health issues but also supports immediate treatment, ultimately aiming to reduce inpatient costs. By making brain health screening more accessible, CenSyn seeks to improve outcomes for diverse patient populations.

DeepScribe Inc is a company that specializes in artificial intelligence-powered medical scribing technology aimed at automating medical documentation for clinicians. Founded in 2017 and based in Berkeley, California, DeepScribe's platform utilizes advanced AI, machine learning, and natural language processing to capture and transcribe clinical conversations in real time. Its system extracts pertinent medical information and organizes it into comprehensive medical notes that seamlessly integrate with electronic health records. By providing a fully automated and user-friendly solution, DeepScribe alleviates the documentation burden on healthcare providers, allowing them to prioritize direct patient care. The company also offers robust integrations with a variety of popular EHR systems, enhancing its utility in clinical settings.

Women aged 20-45 cannot get screened for breast cancer because existing solutions are unreliable. However, 81% want to. At The Blue Box, we have built a pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine with a sensitivity of 83%. In 2024, we’ll launch into the market, bringing The Blue Box to private gynecology clinics with a Diagnostics-as-a-Service subscription model, and a pay-per-test revenue stream that we’ll share with doctors.

Appa Health is a digital mental health management platform aimed at addressing the mental health crisis among teenagers. The company provides accountability to ensure that teens engage with its video-based courses of care and apply the skills they learn. Appa Health connects teens with relatable near-peer mentors, fostering a supportive environment that encourages young individuals to prioritize their mental well-being. The platform integrates research-backed therapeutic methods alongside care navigation specialists and therapists, offering personalized support tailored to each teen's needs. By focusing on relatable connections and accessible resources, Appa Health seeks to empower adolescents to take proactive steps in managing their mental health.

ImmunoMind Inc. is a biotechnology company based in Berkeley, California, established in 2017. The company specializes in developing an AI-based platform that enhances the discovery and design of drug development programs, particularly in the fields of autoimmune diseases, cancer, and orphan diseases. Utilizing proprietary single-cell multi-omics technologies, ImmunoMind’s platform delivers precise analysis of T-cell and B-cell data, aiding researchers in identifying T-cell subpopulations and their immune profiles. This advanced technology supports the design of immunotherapies, including CAR-T therapies, and improves the quality, safety, and efficacy of drug candidates. Additionally, ImmunoMind offers Immunarch AI, an AI platform for precision drug discovery, and Immunarch, an open-source R package for bioinformatics explorations, both of which facilitate in-depth analysis and insights in clinical research and drug development processes.

Aesop Technology is a developer of artificial intelligence solutions focused on reducing prescription-related errors and enhancing patient safety. Founded in 2019 and based in Berkeley, California, the company offers MedGuard, an AI-enhanced safety system that supports various aspects of prescription management, including prescribing, dispensing, administering, and compliance services. Aesop Technology also provides a clinical decision support system that assists healthcare providers by flagging inappropriate prescriptions based on patient diagnosis, age, and gender. By leveraging machine learning, the company's technology aims to improve healthcare quality and safety while streamlining billing-related documentation, ultimately enhancing patient safety and the accuracy of medical billing.

Acunon develops medical diagnostic devices that offer vitro tests for STD patients. The company makes it convenient and accessible for low-income consumers, women, the LGBTQ+ community, and the elderly. Acunon Health is headquartered in Berkeley, California.

Aila Health is a virtual precision health clinic focused on addressing the needs of the approximately 50 million Americans living with autoimmune diseases, with a significant majority being women. Founded in 2020 and headquartered in San Francisco, California, the company leverages a data-driven platform that integrates patient information to support integrative care teams in delivering personalized, multi-specialty care. Aila Health's clinical platform offers access to specialists, health coaches, personalized nutrition, patient education, and remote monitoring devices. By facilitating seamless remote patient monitoring, the platform enables healthcare providers to tailor care management to each patient's unique health history, genetic profile, lifestyle, and environment, ultimately improving health outcomes and reducing costs.

Root Applied Sciences Inc. is a precision pathogen management company that specializes in automated DNA-based sensors designed for monitoring airborne pathogens. Founded in 2018 by Sarah Placella, the company is headquartered in Oakland, California. Its technology collects airborne particles and analyzes their DNA to quantify the presence of pathogens, enabling farmers to apply pesticides at optimal times. This approach allows agricultural growers to be proactive in disease management, promoting sustainability, reducing costs, and minimizing environmental impact. Root Applied Sciences offers its monitoring services through a subscription model, providing alerts directly to users' phones or automatically uploading data to a centralized dashboard for efficient decision-making.

Clinic Price Check is a healthcare technology company based in Santa Clara, California, founded in 2019 by Joanne Rodrigues. The company offers a platform that enables consumers to compare prices for various medical services across more than 350 hospitals in California, featuring cash prices for over 9,000 services. By utilizing public data from hospitals and the Centers for Medicare and Medicaid Services, Clinic Price Check aims to enhance price transparency in the healthcare sector. Its service empowers consumers to make informed decisions regarding their healthcare options, fostering competition among providers and ultimately helping users save money on medical expenses.

DeepRed Technologies, founded in 2019 by Chase Chen, Sanjay Rao, Junqiao Wu, and Kechao Tang, specializes in developing advanced thermal imaging technology aimed at improving the thermal sensitivity of various thermal cameras. The company utilizes phase transition materials with engineered microstructures to enhance temperature resolution, which enables applications across multiple sectors, including healthcare, energy, manufacturing, and artificial intelligence. One of its notable projects focuses on a safer and more accurate breast cancer screening method. Additionally, DeepRed's technology supports a range of uses such as musculoskeletal imaging, integrated circuit inspection, and equipment evaluation, showcasing its versatility and commitment to innovation in critical fields.

DiffZero is a platform that facilitates rehabilitation and training for coaches, athletes, and patients. It specializes in providing support services for ACL rehabilitation, aiming to enhance outcomes for both patients and healthcare professionals. The company offers an interactive and personalized rehabilitation experience grounded in evidence-based practices. Its innovative use of vision technology allows for detailed insights into movement tests, which helps clinicians provide superior care while enabling patients to effectively reach their fitness goals.

mFluidX, Inc. is a biotechnology company that specializes in the manufacture of advanced diagnostic chips for the molecular detection of infectious diseases. Established in 2015 and located in Berkeley, California, the company has developed a compact DNA diagnostic test that is roughly the size of a stick of gum. This innovative chip is designed for rapid deployment in the field, providing results within thirty minutes. Utilizing microfluidic technology, mFluidX's chips employ highly sensitive nucleic acid amplification methods to target pathogens responsible for outbreaks, such as the Zika and Dengue viruses. The self-powered, disposable nature of the diagnostic chip allows it to be produced at a fraction of the cost of traditional lab-based diagnostics, making it a cost-effective solution for addressing global health challenges.

AHEAD Medicine is a health-tech company focused on advancing cancer precision medicine through AI-enabled immunoprofiling diagnostics. Its flagship product, the AHEAD-flow platform, is an innovative machine learning-based tool that automates clinical cytometry analysis for blood cancer patients, significantly enhancing the speed of diagnosis compared to traditional methods. By streamlining the data analysis workflow, AHEAD Medicine aims to improve the efficiency, reproducibility, and scalability of diagnostic services for blood-related diseases. The company is actively engaged in co-development projects with pharmaceutical firms to create companion diagnostics in immuno-oncology. Currently, AHEAD Medicine is seeking funding to establish a quality management system, complete FDA pre-submission processes, and initiate external validation studies for its AHEAD-flow platform.

GenomeUp is a Rome-based healthtech startup that specializes in AI-powered solutions for genetic analysis and clinical decision support. The company aims to serve as a global reference platform to enhance clinical decision-making for hospitals, laboratories, research centers, and pharmaceutical companies. By providing tools that accelerate diagnosis times and improve patient care, GenomeUp seeks to deliver actionable insights for health prevention within a 24-hour timeframe. Emphasizing its commitment to social responsibility, the company has evolved into an Italian Benefit Corporation, prioritizing sustainable and transparent practices that consider the well-being of stakeholders, communities, and the environment.

GenomEdge is a biotechnology company based in Berkeley, California, that specializes in providing DNA testing services. Founded in 2019, the company focuses on utilizing genetic information to enhance health and wellness outcomes for individuals. By leveraging advancements in biotechnology, GenomEdge aims to deliver precise and actionable insights derived from DNA analysis, catering to a growing demand for personalized health solutions.

CredibleMind, Inc. is a digital platform focused on enhancing mental health, emotional well-being, and spiritual growth. Founded in 2018 and based in Sausalito, California, the company offers a comprehensive array of curated resources on topics such as anxiety, depression, stress, sleep, and meditation. By leveraging both expert consultations and AI technology, CredibleMind ensures that users have access to high-quality, evidence-based self-care resources, addressing a significant gap in mental health support. The platform serves a diverse clientele, including employers, insurers, healthcare providers, health departments, and community organizations, aiming to empower individuals to navigate their mental health challenges effectively. CredibleMind, formerly known as LifeView Inc., rebranded in July 2019 to reflect its commitment to providing valuable information for personal growth and well-being.

Taiwan User-Friendly Sensor & Tech is a company focused on addressing food safety challenges, particularly concerning food allergens. Based in China, it develops innovative IoT systems designed for on-site detection of food allergens. The company offers a multi-channel commercial detection module targeted at food processing industries, restaurants, and hypermarkets, as well as a portable device intended for personal use. With a high level of sensitivity, these products provide accurate and detailed information about allergens in food within just two minutes, empowering users to make informed dietary choices.

Vision Science Labs, Inc. is a software company based in Palo Alto, California, specializing in digital tools for the healthcare sector, particularly in vision care. Established in 2017, the company has developed a comprehensive platform for vision therapy that facilitates remote training and assessment for clinicians and patients. Its system allows healthcare providers to assign and monitor vision therapy exercises, enabling effective online management of visual conditions. The platform is designed to enhance patient access to vision care services and supports early detection and treatment of visual conditions related to various diseases in optometry and ophthalmology. Vision Science Labs aims to expand its digital tool offerings beyond eye care into areas such as neurology and physical therapy.

Dieta, Inc. is a San Francisco-based company founded in 2018 that develops an application focused on managing digestive health, particularly for individuals suffering from Irritable Bowel Syndrome (IBS). The app allows users to input detailed information about their food intake, physical activity, medications, and digestive health metrics. By utilizing machine learning algorithms and data science techniques, Dieta's platform analyzes this data to provide personalized insights and recommendations aimed at preventing digestive issues and alleviating symptoms associated with IBS. This innovative approach assists users in improving their overall quality of life by offering tailored guidance based on their unique health profiles.

Serinus Labs, Inc. is a manufacturer of nano-scale silicon gas sensors, established in 2017 and based in Berkeley, California. The company specializes in developing integrated chip-scale gas sensors tailored for various industries, including health and safety, automotive, consumer electronics, and healthcare. Serinus Labs offers custom solutions that address both existing and emerging market needs. In particular, the company focuses on providing ultra-low-power trace gas sensors for Li-ion battery state-of-health monitoring, which enhances battery intelligence in electric vehicles. Through its innovative technology, Serinus Labs aims to meet critical demands across strategic markets.

SynderBio, Inc. is a biotechnology company based in Coralville, Iowa, founded in 2016. It specializes in developing advanced cell separation techniques aimed at enhancing cancer diagnosis and single-cell sequencing. The company's patented technology facilitates the isolation and enrichment of cancer cells from biopsy samples, which is critical for precision cancer medicine. By providing a rapid and label-free approach, SynderBio's methods improve the efficiency of processing mixed biological specimens, thereby enabling researchers and clinicians to more accurately identify genomic markers associated with cancer. This innovation supports timely diagnosis and treatment options, ultimately benefiting oncologists, pathologists, and patients alike.

Medostic, Inc. is a digital therapeutics company headquartered in San Francisco, California, founded in 2017 by Michael Horning and George Brooks. It specializes in developing proprietary integrated inpatient clinical decision support software that personalizes metabolic treatment for critical care patients. The company's solutions focus on improving glycemic control and addressing other critical health indicators by utilizing measurements of glucose, lactate, and various metabolites related to the body's energy state. Medostic's innovative closed-loop systems employ proprietary algorithms to tailor infusion administration of therapeutic formulations, thereby enhancing the management of metabolic and nutritional needs in critically ill patients.

DeepScribe Inc is a company that specializes in artificial intelligence-powered medical scribing technology aimed at automating medical documentation for clinicians. Founded in 2017 and based in Berkeley, California, DeepScribe's platform utilizes advanced AI, machine learning, and natural language processing to capture and transcribe clinical conversations in real time. Its system extracts pertinent medical information and organizes it into comprehensive medical notes that seamlessly integrate with electronic health records. By providing a fully automated and user-friendly solution, DeepScribe alleviates the documentation burden on healthcare providers, allowing them to prioritize direct patient care. The company also offers robust integrations with a variety of popular EHR systems, enhancing its utility in clinical settings.

AHEAD Medicine is a health-tech company focused on advancing cancer precision medicine through AI-enabled immunoprofiling diagnostics. Its flagship product, the AHEAD-flow platform, is an innovative machine learning-based tool that automates clinical cytometry analysis for blood cancer patients, significantly enhancing the speed of diagnosis compared to traditional methods. By streamlining the data analysis workflow, AHEAD Medicine aims to improve the efficiency, reproducibility, and scalability of diagnostic services for blood-related diseases. The company is actively engaged in co-development projects with pharmaceutical firms to create companion diagnostics in immuno-oncology. Currently, AHEAD Medicine is seeking funding to establish a quality management system, complete FDA pre-submission processes, and initiate external validation studies for its AHEAD-flow platform.

Fiat Lux Laboratories is a Biotechnology that develops a Biochemical Processing Sensor. The company was founded in 2017 by Yash Shah and is based in Berkeley, California.

Pinpoint Science, Inc. is a San Francisco-based company focused on developing innovative bio-electronic diagnostics for the rapid detection, diagnosis, and surveillance of infectious diseases globally. Established in 2015, the company has created a diagnostics device that utilizes advanced nanosensor technology. This device employs swappable cartridges to identify pathogens, including viruses, bacteria, and fungi, in various biofluids such as blood and saliva. By enabling label-free electrical detection of specific biomolecules, Pinpoint Science aims to enhance the accuracy and cost-effectiveness of infectious disease diagnostics, ultimately transforming the healthcare sector's approach to disease management.

Blumio, Inc. is a healthcare technology company based in San Francisco, California, founded in 2014. The company specializes in the development of a non-invasive radio frequency wearable sensor designed to measure blood pressure and other cardiovascular diagnostics. Unlike traditional methods that rely on inflatable cuffs, Blumio's sensor utilizes radar technology to detect and analyze the pressure waves traveling through blood vessels, enabling continuous and accurate monitoring of blood pressure throughout daily activities. This innovative approach allows users to track their cardiovascular health in real-time, providing insights that traditional devices cannot offer. By focusing on the dynamic nature of blood pressure and its variations based on activity, Blumio aims to enhance the way individuals monitor their vitals and improve overall health and wellness.

Memora Health Inc. is a San Francisco-based company founded in 2016 that specializes in enterprise healthcare productivity software aimed at automating outpatient communication. It serves as an intelligent care enablement platform designed to enhance the efficiency of care delivery for clinicians and patients alike. By partnering with health systems, health plans, and digital health companies, Memora Health transforms the care process through the digitization and automation of complex clinical workflows. The platform facilitates proactive engagement by triaging patient-reported concerns to the appropriate care team members, while also providing patients with two-way communication and support throughout their care journeys. This approach allows clinicians to concentrate on their core responsibilities, ultimately improving patient outcomes and the overall healthcare experience.

DotLab is a women's healthcare technology company focused on the diagnosis of endometriosis. It has developed a non-invasive diagnostic tool that utilizes biomarkers and machine learning to identify active endometriosis. This innovative approach addresses the complexities associated with the disease's heterogeneity by employing a multi-analyte, algorithmic strategy. Through its technology, DotLab aims to enable early diagnosis and facilitate timely treatment for women suffering from endometriosis, thereby transforming the management and understanding of the condition.

Nosocom Solutions focuses primarily on the development of technology solutions to prevent and reduce Healthcare-Associated Infections (HAI). The company was established in 2012 founded by Naresh Sunkara.

Lioness is a company focused on empowering women through innovative sexual wellness products. It develops an adaptive vibrator equipped with biometric sensors, designed to help women understand and take control of their bodies. This vibrator is paired with an application that allows users to visualize physiological responses and access a supportive community for personalized advice. By utilizing advanced technology, Lioness enables women to gain insights into their sexuality, including arousal patterns and optimal timing for sexual experiences. The company emphasizes a women-centric approach, with leadership and design choices reflecting the needs and preferences of women. By utilizing materials commonly used in medical devices and ergonomics tailored for comfort, Lioness aims to change the conversation surrounding female sexuality and provide valuable tools for self-discovery and empowerment.

Kryptos Biotechnologies, Inc. is a biotechnology company that specializes in developing innovative life science tools aimed at enhancing the understanding of biological complexities for clinicians and scientists. Founded in 2017 by Jinyong Lee and Jun Ho Son, and headquartered in Hayward, California, the company focuses on molecular diagnostic software for the rapid diagnosis of infectious diseases. Kryptos Biotechnologies offers a unique platform featuring an ultrafast photonic polymerase chain reaction (PCR) technology. This system utilizes photothermal heating and plasmonic thin films powered by light-emitting diodes, allowing medical professionals to make timely clinical decisions at a cost-effective rate.

Karuna Labs Inc. specializes in the development of digital therapeutics programs aimed at addressing chronic pain. The company employs a unique approach that combines physical and cognitive retraining to help individuals manage their pain. Its platform utilizes targeted sensorimotor incongruences to deliver comprehensive programs that include physical therapy, pain psychology, cognitive neuroscience, and functional restoration. By offering these innovative solutions, Karuna Labs enables clinics, individuals, and research institutions to effectively treat chronic pain through virtual embodiment training, enhancing the rehabilitation process and improving patient outcomes.

InkSpace Imaging, Inc. is a company focused on developing innovative magnetic resonance imaging (MRI) receive coils, particularly designed for pediatric patients. Founded in 2016 and based in Pleasanton, California, the company aims to enhance the MRI experience by creating ultra-lightweight, customizable coils that contour to the body, providing maximum image quality and reducing the necessity for general anesthesia during exams. These specially designed coils facilitate a more comfortable experience for young patients while also enabling MRI operators to improve efficiency and decrease costs through faster setup times and improved patient comfort.

Vivoo is a wellness application that offers personalized nutrition and lifestyle advice by analyzing users' urine samples. Founded in 2017 and based in Palo Alto, California, the platform provides insights on various health parameters, including vitamin C, magnesium, calcium, salinity, oxidative stress, hydration, ketones, and protein, all derived from weekly at-home urine tests. The app translates this data into actionable recommendations prepared by registered dieticians, nutritionists, and doctors, empowering users to make informed health choices that seamlessly integrate into their daily lives. Through its user-friendly approach, Vivoo helps individuals monitor their health and enhance their well-being.

ResultCare, Inc., established in 2013 and headquartered in San Francisco, California, operates within the healthcare industry as an AI-driven clinical informatics and data analytics company. Founded by physicians and scientists from UCSF, ResultCare focuses on enhancing medical decision-making by providing a collaborative platform that eliminates uncertainties in clinical practices. The company has developed one of the largest clinical databases globally, leveraging machine learning and natural language processing to facilitate an evidence-based approach in identifying optimal and cost-effective laboratory and diagnostic tests. ResultCare's platform supports healthcare providers by utilizing real-time research data to improve the reproducibility of medical practices and to identify trends that help optimize care delivery, ultimately aiming to enhance patient outcomes while controlling costs.

Darmiyan, Inc. is a biotechnology company focused on early detection and monitoring of neurodegenerative diseases, including Alzheimer's disease. Founded in 2014 and based in San Francisco, California, the company has developed a proprietary diagnostic software platform known as BrainSee. This Software as a Service (SaaS) platform utilizes standard clinical brain MRI scans and basic cognitive tests to generate detailed brain maps and quantifications of neurodegeneration in each voxel. BrainSee provides a summary score reflecting an individual's brain health and the likelihood of future cognitive decline, allowing for diagnosis at early stages when treatment options are most effective. The technology, referred to as The Virtual Microscope, employs advanced medical image analysis and artificial intelligence, underpinned by over 40 years of neuroscience research. It has undergone successful third-party validation in the United States and Canada, demonstrating high accuracy and consistency in predicting mild cognitive impairment, and has received endorsements from notable figures in the medical community.

Genomelink is a platform that enables individuals to explore insights from their DNA data while assisting businesses in leveraging this information for marketing and research purposes. The company, founded by experienced professionals in the consumer genomics field, offers a personal DNA cloud data upload application that allows users to upload their raw DNA data files. Through its platform, members can uncover their identities and traits using intuitive visualizations and educational content, promoting a clear understanding of their genetic information. Genomelink's commitment to transparency ensures that users can engage deeply with their DNA data, while the company also collaborates with prestigious institutions and investors to advance its mission in the genomics sector.

SwiftMotion is a company that specializes in developing wearable sensors and analytics aimed at enhancing the health and safety of industrial workers. The company's innovative ergonomic systems utilize full-body motion capture technology to conduct precise ergonomic risk assessments, while also capturing load and force data to identify potential risks. By offering these insights, SwiftMotion enables clients in sectors such as warehousing, distribution centers, airport transit, automotive, and insurance to design effective interventions that reduce injury rates. This not only promotes worker well-being but also helps organizations decrease costs associated with workers' compensation.

Angilytics is a company focused on cardiovascular wellness through the development of a wearable wristband that provides essential health metrics, including blood pressure and heart rate. Utilizing a patented sensor fusion technology combined with machine learning algorithms, the wristband enables healthcare professionals to remotely monitor patients with various cardiovascular conditions such as heart failure, atrial fibrillation, and myocardial infarction. By facilitating timely and informed medical interventions, Angilytics aims to reduce hospital readmission rates and lower overall healthcare costs, making it easier for doctors to manage and treat heart diseases efficiently.

Cocoon Cam is a technology company based in Silicon Valley that specializes in remote health monitoring through innovative computer vision technology. Its flagship product is a groundbreaking baby monitor that passively collects video feeds to analyze vital signs, providing parents with real-time alerts and historical data on their baby's breathing, movement, and future metrics such as heart rate and temperature fluctuations. This non-invasive approach distinguishes Cocoon Cam from traditional baby monitoring solutions, as it requires no wires or wearable devices. By leveraging cloud-based data analysis, the company empowers parents with instant access to critical health information about their children, ensuring peace of mind without compromising comfort.

Telelytics is a provider of a telemedicine platform that focuses on enhancing healthcare delivery through technology. The platform utilizes artificial intelligence and machine learning to analyze health records, facilitating video consultations between patients and doctors. By implementing innovative therapeutic modalities, Telelytics aims to improve access to appropriate care for individuals, enabling clinics to better serve their patients through smart scheduling and effective use-case matching.

Stroll, Inc. specializes in developing an integrated referral management application designed to enhance patient care by providing seamless access to healthcare services. The platform includes features such as automatic insurance verification, out-of-pocket cost estimates, clinical decision support, prior authorization, real-time scheduling, and patient reminders. By leveraging tools like real-time eligibility checks, insurance co-pay estimates, and quality metrics, Stroll enables patients to identify suitable care options based on their individual needs. The comprehensive patient engagement system ensures effective communication before, during, and after medical appointments, facilitating better preparation and follow-up. Stroll's innovative cloud image sharing technology and physician-specific analytics further streamline the sharing of medical information, addressing common challenges in the healthcare space related to compatibility and transparency. Founded in 2013 and based in San Francisco, California, Stroll aims to simplify the healthcare experience for both patients and providers.

Outcomes.com focuses on enhancing healthcare through technology by aligning incentives to promote data-driven care and improve patient outcomes. The company develops pharmacy management systems and clinical applications tailored for various healthcare settings, including assisted living and hospital pharmacies. Its platforms provide valuable insights and analytics, facilitate insurance claims processing, enable e-prescription connectivity, and streamline pharmacy workflow management. By offering these services, Outcomes.com aims to assist clients in optimizing operations, expanding their businesses, increasing patient engagement, and ultimately achieving better healthcare outcomes.

Lioness is a company focused on empowering women through innovative sexual wellness products. It develops an adaptive vibrator equipped with biometric sensors, designed to help women understand and take control of their bodies. This vibrator is paired with an application that allows users to visualize physiological responses and access a supportive community for personalized advice. By utilizing advanced technology, Lioness enables women to gain insights into their sexuality, including arousal patterns and optimal timing for sexual experiences. The company emphasizes a women-centric approach, with leadership and design choices reflecting the needs and preferences of women. By utilizing materials commonly used in medical devices and ergonomics tailored for comfort, Lioness aims to change the conversation surrounding female sexuality and provide valuable tools for self-discovery and empowerment.

Picosense is a technology company focused on transforming the heart monitoring industry through the development of a miniaturized, contact-less heart monitoring device. The company has created a millimeter-scale device that utilizes an innovative combination of Magnetoresistive (MR) sensors and Microelectromechanical (MEMS) resonators. This advanced integration allows for an unprecedented level of sensitivity in detecting low-frequency magnetic signals, while maintaining low power consumption, volume, and mass. Picosense's chip-scale sensors are specifically designed to measure picotesla magnetic signals, enabling accurate heart rate monitoring for patients.

Privail is a company focused on developing point-of-care diagnostics for the early detection of infectious diseases, with an initial emphasis on HIV. The company aims to create simple and affordable tests that empower patients to seek timely medical treatment, thereby improving their quality of life. Privail is comprised of a diverse team of scientists and engineers from the University of California, Berkeley, and the University of California, San Francisco, united by a shared mission to enhance healthcare access for underserved populations. The company also designs healthcare devices for tracking and detecting diseases, offering in-home testing solutions suitable for both developing and developed nations.

Zephyrus Biosciences, Inc. is a life science research tools company based in Berkeley, California, founded in 2013. The company specializes in developing and commercializing innovative tools for protein analysis at the single-cell level. Its flagship product, the scWestern System, allows for western blotting on individual cells, a significant advancement in the field of single-cell analysis. By utilizing microfluidics technology, the scWestern system partitions single cells into micro-wells, lyses them, and performs SDS-PAGE separation on each cell lysate. This technology facilitates the identification of cellular subpopulations, the analysis of enriched cell populations post-FACS sorting, and studies on cell signaling and cancer heterogeneity, among other applications. Researchers leverage Zephyrus's products to gain deeper insights into various biological fields, including cancer, stem cells, neurology, and human disease development, ultimately aiming to enhance healthcare outcomes.

Cortera Neurotechnologies, Inc. specializes in the design and development of implantable medical devices that focus on diagnosing and treating incurable neurological conditions. The company leverages over five years of expertise in NeuroEngineering to advance its innovative solutions within the neurodevices industry, which is valued at $4.5 billion. Cortera's wireless brain-machine devices are intended to enhance patient care and quality of life while also supporting advanced neuroscience research. By integrating circuit technology for brain sensing and stimulation, Cortera aims to provide medical professionals with cutting-edge tools to improve outcomes for individuals suffering from neurological disorders.

Crohnology is a patient-powered research platform designed to empower individuals with chronic medical conditions to contribute to research related to their own health. The company operates a patient-centered information-sharing network that connects patients, their families, and friends, fostering a collaborative environment for sharing health and treatment information. This platform enables users to engage with each other for social support while tracking and sharing their health experiences. By facilitating these connections, Crohnology aims to enhance the understanding and management of chronic conditions through collective patient insights.